Effectiveness and safety of erythropoiesis-stimulating agent use in the perioperative period

By Tran Diane HD   Wong Gordon TC   Chee Yee Eot   Irwin Michael G  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 1, 2014-01 ,pp. : 51-61

Informa Healthcare

Access to resources Recommend Favorite

Absorption, distribution, metabolism and excretion of peginesatide, a novel erythropoiesis-stimulating agent, in rats

By Woodburn Kathryn W.   Holmes Christopher P.   Wilson Susan D.   Fong Kei-Lai   Press Randall J.   Moriya Yuu   Tagawa Yoshihiko  

Xenobiotica, Vol. 42, Iss. 7, 2012-07 ,pp. : 660-670

Informa Healthcare

Access to resources Recommend Favorite

The clinical potential of novel erythropoiesis stimulating protein

By Hörl Walter H   Sunder-Plassmann Gere  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 4, 2001-07 ,pp. : 733-739

Informa Healthcare

Access to resources Recommend Favorite

Catestatin is useful in detecting patients with stage B heart failure

By Zhu Dan   Wang Fangfang   Yu Haiyi   Mi Lin   Gao Wei  

Biomarkers, Vol. 16, Iss. 8, 2011-12 ,pp. : 691-697

Informa Healthcare

Access to resources Recommend Favorite

Bone marrow-derived mononuclear cell therapy for patients with ischemic heart disease and ischemic heart failure

By Wen Yanting   Chen Bing   Wang Chen   Ma Xiaodong   Gao Qian  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 12, 2012-12 ,pp. : 1563-1573

Informa Healthcare

Access to resources Recommend Favorite